Pharmacological strategies to prevent contrast-induced acute kidney injury. - Wikidata - awgldk - TriplyDB

Pharmacological strategies to prevent contrast-induced acute kidney injury.

Pharmacological strategies to prevent contrast-induced acute kidney injury.

http://www.wikidata.org/entity/Q37639849

about

Acute kidney injury in the perioperative period and in intensive care units (excluding renal replacement therapies)Histopathological Evaluation of Contrast-Induced Acute Kidney Injury Rodent Models Relaxin Attenuates Contrast-Induced Human Proximal Tubular Epithelial Cell Apoptosis by Activation of the PI3K/Akt Signaling Pathway In Vitro.Resin from Virola oleifera Protects Against Radiocontrast-Induced Nephropathy in Mice Resveratrol alleviates the cytotoxicity induced by the radiocontrast agent, ioxitalamate, by reducing the production of reactive oxygen species in HK-2 human renal proximal tubule epithelial cells in vitro Contemporary practice patterns related to the risk of acute kidney injury in the catheterization laboratory: Results from a survey of Society of Cardiovascular Angiography and Intervention (SCAI) cardiologists.Could Vitamin E Prevent Contrast-Induced Acute Kidney Injury? A Systematic Review and Meta-Analysis.Use of the RenalGuard system to prevent contrast-induced AKI: A meta-analysis.N-acetylcysteine ameliorates contrast‑induced kidney injury in rats with unilateral hydronephrosis.Prevention of contrast-induced nephropathy through a knowledge of its pathogenesis and risk factors

P2860

Q26745670-A031C29C-606F-4BB1-9CF4-79EF3A284C16 Q28077146-3E20B7CD-568A-403D-8938-DBC5E1CBBBF8 Q32176355-E7D70231-03EB-40E4-AE74-651D7E13944A Q35870556-E4821713-49FD-4D97-8B78-3240700BA983 Q38819221-A2B00E6B-184D-4086-B6C0-050D5B42D50B Q39674875-68CE93EC-E1EE-4968-95C3-BFB0AB31DB92 Q41285597-9991C072-5A9D-4BF1-A1F6-226624D220A8 Q48132610-2C551450-5334-4E91-A3AD-F6B1231BC43C Q49882505-7DF40157-2614-4970-B0F6-EF53712FD4A3 Q59100924-C0E2086B-E384-4A80-9A80-88EC1A5D3DA6

P2860

Pharmacological strategies to prevent contrast-induced acute kidney injury.

http://www.wikidata.org/entity/Q37639849

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 26 February 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Pharmacological strategies to prevent contrast-induced acute kidney injury.

@en

Pharmacological strategies to prevent contrast-induced acute kidney injury.

@nl

type

label

Pharmacological strategies to prevent contrast-induced acute kidney injury.

@en

Pharmacological strategies to prevent contrast-induced acute kidney injury.

@nl

prefLabel

Pharmacological strategies to prevent contrast-induced acute kidney injury.

@en

Pharmacological strategies to prevent contrast-induced acute kidney injury.

@nl

P1433

Q37639849-066E805A-832A-42E3-9F2F-82B9BEDAB9A3

P1476

Q37639849-BB155740-AD29-438F-A2D9-156D90C9DEBC

P2093

Q37639849-2BBA44A6-FD17-443F-A708-254573A3ACC3

P275

Q37639849-E051A6CB-A3C9-4271-980B-BD318F578FC6

P2860

Q37639849-01ECF69C-B091-4D01-87C2-D9F2469DB8C3

Q37639849-022081FD-AABE-44AA-998C-EECE6B80BCE7

Q37639849-0365CE0B-4990-4EFA-8BB8-6E81CC99A6C4

Q37639849-03B4B4A4-71AB-4CC6-8D7B-3595861B85B9

Q37639849-089203A5-94FC-4888-A714-D3D4F8638596

Q37639849-0EBF3D28-1488-4781-8A23-DD4868AFEA2F

Q37639849-109CDD69-8445-4B8F-BEF8-7BE1A625F80E

Q37639849-135F4CD0-6174-417E-BF97-B55D1D341B8B

Q37639849-18A6D9EB-F2FC-4013-8621-D5340226B67A

Q37639849-1FA5EAC4-D931-4EFE-B592-13BAA47973FD

P304

Q37639849-3BB881E7-F1E4-48A7-B5F9-2181D3E32AA6

P31

Q37639849-EF1E72C4-9851-4256-843F-7F08DC0501BB

Q37639849-F1BE2B96-1631-4118-A356-34E6F31DE02D

P356

Q37639849-67C53C1B-B586-49B7-8A13-386E3CF19BDC

P407

Q37639849-972EBAF7-1D83-4DCF-B69F-F8657ABB0C34

P478

Q37639849-C3951713-9BD3-4302-A550-561DA5920A03

P50

Q37639849-F39D1363-E2B5-46CA-A006-220CFC524902

P5008

Q37639849-6B5AD44E-AB16-4599-8441-5FDBF09075EE

P577

Q37639849-8AAB4FFD-F6E8-478E-9F74-03598AD2FAFA

P5875

Q37639849-A71E72EF-2485-4F00-AE44-3FC680608267

P698

Q37639849-786F4635-5FE3-4470-A26F-C360431AC3D6

P921

Q37639849-8395067D-3220-44BB-A1DC-E425C7DD6548

Q37639849-FA2E17D3-3C69-4250-B913-E8299CA11FBF

P932

Q37639849-B2691F19-CE22-416D-81E9-9D35738B203A

P356

P1433

BioMed Research International

P1476

Pharmacological strategies to prevent contrast-induced acute kidney injury.

@en

P2093

Adis Tasanarong

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 3.0 Unported

P2860

Contrast media and the kidney: European Society of Urogenital Radiology (ESUR) Guidelines

Acetylcysteine for prevention of contrast-induced nephropathy after intravascular angiography: a systematic review and meta-analysis

Measures used to treat contrast-induced nephropathy: overview of reviews

Theophylline for prevention of contrast-induced nephropathy: a systematic review and meta-analysis

Contrast-induced nephropathy

Prostaglandins protect kidneys against ischemic and toxic injury by a cellular effect

The antioxidant defense protein heme oxygenase 1 is a novel target for statins in endothelial cells.

Meta-analysis of randomized clinical trials on the usefulness of acetylcysteine for prevention of contrast nephropathy.

A meta-analysis of N-acetylcysteine in contrast-induced nephrotoxicity: unsupervised clustering to resolve heterogeneity.

Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy.

P304

236930

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2014/236930

http://www.w3.org/2001/XMLSchema#string

P407

P478

2014

http://www.w3.org/2001/XMLSchema#string

P50

Pattharawin Pattharanitima

P5008

P577

2014-02-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261521704

http://www.w3.org/2001/XMLSchema#string

P698

24719848

http://www.w3.org/2001/XMLSchema#string

P921

acute kidney injury

P932

3955653

http://www.w3.org/2001/XMLSchema#string